Investigational Drug Information for Sarizotan
✉ Email this page to a colleague
What is the development status for investigational drug Sarizotan?
Sarizotan is an investigational drug.
There have been 5 clinical trials for Sarizotan.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 30th 2004.
The most common disease conditions in clinical trials are Dyskinesias, Parkinson Disease, and Movement Disorders. The leading clinical trial sponsors are EMD Serono, Merck KGaA, and Merck KGaA, Darmstadt, Germany.
Summary for Sarizotan
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 639 |
| WIPO Patent Applications | 301 |
| Japanese Patent Applications | 63 |
| Clinical Trial Progress | Phase 3 (2004-09-30) |
| Vendors | 26 |
Recent Clinical Trials for Sarizotan
| Title | Sponsor | Phase |
|---|---|---|
| Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms | Newron | Phase 2/Phase 3 |
| Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms | Newron Pharmaceuticals SPA | Phase 2/Phase 3 |
| Sarizotan in the Treatment of Neuroleptic-induced Tardive Dyskinesia | Merck KGaA | N/A |
Clinical Trial Summary for Sarizotan
Top disease conditions for Sarizotan
Top clinical trial sponsors for Sarizotan
US Patents for Sarizotan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
